Dept. of Breast &癌と化学療法Kurebayashi J.Tumor markers in breast cancer.Gan To K agaku Ryoho.2004;31:2077-2081.Ferrandina G,Scambia Bardelli F. Tumor markers in breast cancer[J].British Journal of Cancer 1997,76(04).Kurebayashi J. Tumor markers in breast cancer[J].Gan To Kagaku ...
The purpose of this study was to identify and standardize optimal decision criteria for maximizing the effectiveness of tumor markers in clinical use during the follow-up of patients operated on for breast cancer. The study was prospectively performed on 859 patients enrolled in 10 institutions. A ...
Breast cancer is one of the most common cancer in women, presented with a lump and skin colour change, is one of the commonest cancer in women. A wide variety of tumor markers viz. uPA, BRCA1 & 2, Ki76, ER, PR, HER etc. are used for establishing carcinoma of breast but none bei...
Breast cancer: Screening, detection, tumor markers and surgical managementR. IsaacB. VivianR. AvrahamU. LibsonL. Durst ArieJournal of Tumor Marker Oncology
Tumor markers are substances, often proteins, that are produced by the cancer tissue itself or sometimes by the body in response to cancer growth. Because some of these substances can be detected in body samples such as blood, urine, and tissue, these markers may be used, along with other ...
Deleterious inflammation is a primary feature of breast cancer. Accumulating evidence demonstrates that macrophages, the most abundant leukocyte population in mammary tumors, have a critical role at each stage of cancer progression. Such tumor-associated
Tumor markers in breast cancer follow-up: A potentially useful parameter still awaiting definitive assessment Background: Although tumor markers are frequently used in the follow-up of patients with breast cancer, two points are still being debated: 1) their cost/e... M Gion,P Barioli,R Mione...
ABC-transporter expression is a crucial mechanism of tumor resistance and was recently also associated with cancer initiating cells (CIC). Flow cytometry was applied to detect the expression of CIC-markers, ABCB1 and ABCG2 in human brain... S Huber 被引量: 0发表: 2016年 CA 125 Immune Comp...
Since tumor infiltrating lymphocytes (TILs) are the main actors in the response against cancer cells, they might constitute surrogate markers of the immune balance between the host and the tumor. In breast cancer, the results of studies addressing the issue of tumor immune cell infiltration have ...
Cancer Cell 11:539–554 Article PubMed CAS Google Scholar Davies G, Cunnick GH, Mansel RE et al (2004) Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer. Clin Exp Metastasis 21:31–...